What We're Reading: Page 9
Industry reads hand-picked by our editors
Jun 11, 2025
-
Science
Science’s reform movement should have seen Trump’s call for ‘gold standard science’ coming, critics say
-
Fierce Biotech
Pfizer CEO talks Chinese due diligence, ADC synergies to justify $6B bet on ‘fabulous’ bispecific
-
The Wall Street Journal
These Diabetes Drugs Are Finding New Life as an Antiaging Hack
Jun 10, 2025
-
Bloomberg
Chinese Firm Halts Production of Controversial Alzheimer’s Drug
-
The Wall Street Journal
For Patients With Rare Blood Cancer, New Drug Offers Relief
-
Associated Press
NIH scientists publish declaration criticizing Trump’s deep cuts in public health research
Jun 09, 2025
Jun 06, 2025
Jun 05, 2025
Jun 04, 2025
-
The Economist
The Alzheimer’s drug pipeline is healthier than you might think
-
The New York Times
From No Hope to a Potential Cure for a Deadly Blood Cancer
-
BioCentury
Lawsuit challenges layoffs at FDA, other HHS agencies
Jun 03, 2025
-
The Wall Street Journal
How Moderna Went From Pandemic Hero to Vaccine Victim
-
The Financial Times
Merck held talks to buy Swiss biotech MoonLake for more than $3bn
-
Bloomberg
AI Drug Startup Touts Promising Advance in Treating Lung Disease
Previous
